Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Lancet. Oncology|February 17, 2019
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trialDavid Ball, G Tao Mai, Shalini Vinod, et al.Trials|March 29, 2023
Study protocol for a randomised controlled trial to evaluate the use of melanoma surveillance photography to the Improve early detection of MelanomA in ultra-hiGh and high-risk patiEnts (the IMAGE trial)Mabel K Yan, Anne E Cust, H Peter Soyer, et al.Nature Reviews. Cancer|May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancerFlurina A M Saner, Alan Herschtal, Brad H Nelson, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide TherapyRodney J Hicks, Price Jackson, Grace Kong, et al.The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trialAndrew Kneebone, Carol Fraser-Browne, Gillian M Duchesne, et al.Blood|December 19, 2014
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsDavid T Yeung, Michael P Osborn, Deborah L White, et al.Lancet (London, England)|March 27, 2020
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre studyMichael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, et al.Trials|November 23, 2024
Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipientsLea Dousset, Daniel C Chambers, Angela Webster, et al.BMJ Open Sport & Exercise Medicine|February 25, 2026
Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MSLisa Grech, Belinda Beck, David Scott, et al.The New England Journal of Medicine|December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesStephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.Pageof 6